doi: 10.1155/2011/736841.
Epub 2010 Oct 13.
Ewing's Sarcoma and Second Malignancies
Affiliations
- PMID: 20981341
- PMCID: PMC2957850
- DOI: 10.1155/2011/736841
Item in Clipboard
Ewing's Sarcoma and Second Malignancies
Sarcoma.
2011.
Abstract
Ewing's sarcoma (ES) is a rare tumor that is most common in children and young adults. Late effects of ES therapy include second cancers, a tragic outcome for survivors of such a young age. This paper will explore the frequencies and types of malignancies that occur after ES. Additionally, it will review how second malignancies have changed with the shift in treatment from high-dose radiation to chemotherapy regimens including alkylators and epipodophyllotoxins. The risk of additional cancers in ES survivors will also be compared to survivors of other childhood cancers. Finally, the possible genetic contribution to ES and second malignancies will be discussed.
Similar articles
-
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.J Clin Oncol. 1996 Oct;14(10):2818-25. doi: 10.1200/JCO.1996.14.10.2818. J Clin Oncol. 1996. PMID: 8874344
-
Ewing's sarcoma and the development of secondary malignancies.Clin Orthop Relat Res. 2003 Oct;(415):82-9. doi: 10.1097/01.blo.0000093900.12372.e4. Clin Orthop Relat Res. 2003. PMID: 14612633
-
Second cancers in long-term survivors of Ewing's sarcoma.Clin Orthop Relat Res. 1992 Jan;(274):275-81. Clin Orthop Relat Res. 1992. PMID: 1729013
-
Prevalence of low bone mineral density and risk of fractures in osteosarcoma and Ewing's sarcoma survivors: A scoping review.J Bone Oncol. 2022 Dec 7;38:100464. doi: 10.1016/j.jbo.2022.100464. eCollection 2023 Feb. J Bone Oncol. 2022. PMID: 36560961 Free PMC article.
-
Ewing's sarcoma family of tumors: an overview from diagnosis to survivorship.Clin J Oncol Nurs. 2008 Feb;12(1):89-97. doi: 10.1188/08.CJON.89-97. Clin J Oncol Nurs. 2008. PMID: 18258578 Review.
Cited by
-
Secondary Malignancies after Ewing Sarcoma-Epidemiological and Clinical Analysis of an International Trial Registry.Cancers (Basel). 2022 Nov 30;14(23):5920. doi: 10.3390/cancers14235920. Cancers (Basel). 2022. PMID: 36497401 Free PMC article.
-
Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors.Children (Basel). 2019 Nov 29;6(12):130. doi: 10.3390/children6120130. Children (Basel). 2019. PMID: 31795500 Free PMC article.
-
Increased risk for other cancers in individuals with Ewing sarcoma and their relatives.Cancer Med. 2019 Dec;8(18):7924-7930. doi: 10.1002/cam4.2575. Epub 2019 Oct 31. Cancer Med. 2019. PMID: 31670911 Free PMC article.
-
Ewing Sarcoma as Secondary Malignant Neoplasm-Epidemiological and Clinical Analysis of an International Trial Registry.Cancers (Basel). 2022 Nov 30;14(23):5935. doi: 10.3390/cancers14235935. Cancers (Basel). 2022. PMID: 36497417 Free PMC article.
-
Development of Secondary Acute Myeloid Leukemia in a Pediatric Patient Concurrently Receiving Primary Therapy for Ewing Sarcoma.J Pediatr Hematol Oncol. 2017 Oct;39(7):e370-e372. doi: 10.1097/MPH.0000000000000924. J Pediatr Hematol Oncol. 2017. PMID: 28816792 Free PMC article.
References
-
- Phillips RF, Higinbotham NL. The curability of Ewing’s endothelioma of bone in children. The Journal of Pediatrics. 1967;70(3):391–397. - PubMed
-
- Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. New England Journal of Medicine. 2003;348(8):694–701. - PubMed
-
- Mike V, Meadows AT, D’Angio GJ. Incidence of second malignant neoplasms in children: results of an international study. Lancet. 1982;2(8311):1326–1331. - PubMed
-
- Tucker MA, D’Angio GJ, Boice JD, Jr., et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. New England Journal of Medicine. 1987;317(10):588–593. - PubMed
-
- Strong LC, Herson J, Osborne BM, Sutow WW. Risk of radiation related subsequent malignant tumors in survivors of Ewing’s sarcoma. Journal of the National Cancer Institute. 1979;62(6):1401–1406. - PubMed
LinkOut - more resources
Full Text Sources
